To measure the bacterial genome in ocular fluids and to analyse the clinical relevance of infectious endophthalmitis. Methods Nineteen ocular fluid samples (eight aqueous humour and 11 vitreous fluid samples) were collected from 19 patients with suspected bacterial endophthalmitis. Fifty ocular samples from uveitis patients were also collected along with 40 samples from patients without ocular inflammation and used as controls. Bacterial ribosomal DNA (16S rDNA) was measured by a quantitative PCR assay. Results Bacterial 16S rDNA was detected in patients with clinically suspected bacterial endophthalmitis (18/ 19, 95%). With the exception of one case, high copy numbers of bacterial DNA were detected (1.7310 3 e1.7310
INTRODUCTION
Bacterial infectious endophthalmitis occurs due to exogenous infections, such as those arising from trauma and intraocular surgery, or from endogenous infections, such as systemic infectious disorders. Previous studies have used PCR to demonstrate the presence of bacterial DNA in the ocular fluids in patients with infectious endophthalmitis. 1e10 PCR has often been used to provide evidence of bacterial involvement in the eyes with suspected intraocular infections. 8 These suspected infections include idiopathic endophthalmitis and uveitis. Recent advances in molecular biology along with the use of real-time PCR have made it possible to determine quantitative measurements of the viral load associated with viral diseases in the eye. 11e13 Several studies have recently reported finding the bacterial ribosomal RNA gene (16S rDNA) in the ocular fluids of patients with infectious endophthalmitis. 4 8 10 With primers of the bacterial 16S rRNA gene, broad-range PCR can be used to detect the presence of bacteria within the samples. In endophthalmitis patients with previous intravitreal administration of antibiotics, PCR methodology has been shown to be more effective than bacterial cultures in detecting bacterial DNA in the ocular fluids. 10 However, even broad-range PCR has not been able to determine quantitative information for the bacterial genome in the ocular sample.
In the present study, after collecting ocular samples from patients with suspected intraocular infections, which included bacterial infectious endophthalmitis, we attempted to detect and then measure the bacterial genome using real-time quantitative PCR with primers for 16S rDNA amplifications.
MATERIAL AND METHODS Subjects
Based upon medical history and clinical observations, 69 patients with endophthalmitis and uveitis were consecutively enrolled in a prospective study that was conducted from 2008 to 2009 at the Tokyo Medical and Dental University Hospital. Samples of aqueous humour and vitreous fluids were collected from all patients. Nineteen patients (19 eyes: eight aqueous humour and 11 vitreous fluids) had bacterial infectious endophthalmitis. Of these 19 patients, six had acute postoperative endophthalmitis, four had late postoperative endophthalmitis, one had post-traumatic endophthalmitis, five had endogenous endophthalmitis, two had keratitis-associated endophthalmitis, and one had endophthalmitis after intravitreal injections of bevacizumab.
The second patient group was also a prospective study, and 50 ocular samples were collected from various patients with uveitis. The underlying pathology included idiopathic uveitis (n¼21), herpetic keratouveitis (n¼3), herpetic anterior iridocyclitis (n¼3), acute retinal necrosis (n¼5), cytomegalovirus retinitis (n¼2), toxoplasmosis (n¼3), toxocariasis (n¼2), sarcoidosis (n¼2), HTLV-1-associated uveitis (n¼1), toxic lens syndrome (n¼1), Candida endophthalmitis (n¼2) and intraocular lymphoma (n¼5). In this study, fungal endophthalmitis cases such as Candida endophthalmitis were classified as being part of this patient group. All the patients displayed active intraocular inflammation at the time of sampling.
In addition to the patient groups, we also analysed samples from a control group. These patients were enrolled in this prospective study in 2009. Forty samples (20 aqueous humour and 20 vitreous fluids) were collected from patients who did not have any type of ocular inflammation (age-related cataract, macular oedema secondary to branch retinal vein occlusion, retinal detachment, idiopathic macular hole or idiopathic epiretinal membrane).
For the ocular sampling (asepsis), the following procedures were performed in all subjects. In all of the eyes that were sampled, the ocular surfaces, including the conjunctival sacs, were rinsed once with an aqueous povidone iodine solution. Subsequently, all of these eyes were then rinsed once with a balanced-salt solution. A 0.1 ml aliquot of aqueous humour was collected aseptically in a syringe with a 30 G needle. Half of the sample was then transferred into a pre-sterilised microfuge tube and used for PCR.
In patients with endophthalmitis/uveitis who were undergoing vitreous surgery, uncontaminated non-diluted vitreous fluid samples (0.5e1.0 ml) were collected during diagnostic pars plana vitrectomy (PPV). Immediately after collection, 100 ml of the sample was transferred into a pre-sterilised microfuge tube and used for PCR. None of the asepsis samples used for analysis came from patients being given systemic antibiotics or from patients who were receiving intraocular antibiotic injections.
Conventional microbiological investigations
The Bacteria Work Station of the Tokyo Medical and Dental University Hospital processed all specimens (aqueous humour and vitreous fluids) within 1 h after the sample collection, with standard methods followed for the isolation and identification of the aerobic and anaerobic bacterial cultures. The culture methods followed conventional techniques that have been previously published. 14 15 Cultures were incubated for up to 7 days, with those lacking growth designated as culture-negative. Cytospin smears of the specimens were stained using Gram's method for detection of bacteria.
Quantitative PCR
DNA was extracted from samples using a DNA minikit (Qiagen, Valencia, California, USA) installed on a Robotic workstation for automated purification of nucleic acids (BioRobot E21, Qiagen). The real-time PCR was performed using Amplitaq Gold and the Real-Time PCR 7300 system (Applied Biosystems, Foster City, California, USA). Primers and probes of bacterial 16S rDNA and the PCR conditions are described elsewhere. 16 The sense primer (Bac349F) was 5 9 -AGGCAGCAGTDRGGAAT-3 9 and the antisense primer (Bac806R) was 5
9 -GGACTACYVGGGTATCT-AAT-3 9 . The TaqMan probe (Bac516F) was 5 9 -FAM-TGCCAGC-AGCCGCGGTAATACRDAG-TAMRA-3 9 . Products were subjected to 50 cycles of PCR amplification, with cycling conditions set at 958C for 10 min, followed by 50 cycles at 958C for 15 s and 608C for 1 min. Amplification of the human b-globulin gene served as an internal positive extraction and amplification control. Bacterial copy number values of more than 100 copies/ml in the sample were considered to be significant.
Sensitivity of TaqMan real-time PCR
To confirm the real-time PCR assay sensitivity, the 458 bp fragments were amplified from the DNA of Staphylococcus aureus (NBRC 12732) with Bac349F and Bac806R. The PCR fragments were inserted into the pGEM cloning plasmid with the pGEM TEasy Vector Cloning System I kit (Promega, Tokyo, Japan). The plasmid was digested with restriction enzyme ScaI. Linearised plasmid was controlled by gel electrophoresis and quantified by using the Smart Ladder DNA size and mass marker (Wako, Tokyo, Japan) and the OD260 measurement. Standard curves were constructed from serial 10-fold dilutions of linearised plasmid DNA with 10 ng/ml MS2 RNA (Basel, Roche, Switzerland). The detection limit and standard range of the TaqMan real-time PCR were determined by using serial 10-fold dilutions of linearised plasmid. The standard range of DNA was linearly quantified from one to nine log DNA copies, with a detection limit of 10 copies. The negative control (nucleasefree water) was not detected.
PCR FOR 16S rRNA GENE AND SEQUENCE ANALYSIS
PCR mix (50 ml volumes) was prepared from Low-DNA AmpliTaq Gold DNA polymerase LD (Applied Biosystems). The mix comprised dATP, dGTP, dCTP, dTTP, 2 mM MgCl 2 and 13Gold buffer, along with each of the primers (500 nM) (forward primer fD1-AGAGTTTGATCCTGGCTCAG; reverse primer rp2-ACGGCTACCTTGTTACGACTT). 17 Template DNA, 1.25U of AmpliTaq Gold DNA polymerase LD (Applied Biosystems), and nuclease-free water were added to the sample. The PCR assay was performed using the Takara Thermal Cycler TP-400 (Takara Bio Inc., Shiga, Japan). The cycling conditions used were: 958C for 10 min, followed by 35 cycles at 958C for 15 s, 428C for 30 s, and 728C for 4 min. Gel electrophoresis was performed using a 0.8% agarose gel (Takara Bio Inc.) in 40 mmol/l Tris, 1 mmol/l EDTA for 30 min at 100 V, followed by ethidium bromide staining. Before cycle sequencing, amplicons were purified using the Qiaquick PCR purification kit (Qiagen) according to the manufacturer's protocol. Cycle sequencing was performed by forward and reverse priming using the Big Dye v3.1 Terminator Reaction kit (Applied Biosystems). The PCR assay was performed using a Perkin Elmer 9700 with cycling conditions set at: 958C for 30 s, followed by 25 cycles at 968C for 10 s, 508C for 5 s and 608C for 4 min. Electrophoresis was conducted in a 3130xl genetic analyser (Applied Biosystems).
We used the DNA sequence analysis to examine patients suspected of having bacterial endophthalmitis (patient samples that only had high amounts of total DNA and detected high copy numbers of bacterial 16S rDNA). Basic local alignment search tool (BLAST) analysis was used to examine the DNA sequences. The 16S rDNA sequences obtained were compared with those available in the GenBank BLAST database (http:// blast.ncbi.nlm.nih.gov/Blast.cgi). Using a previously published method, 18 positive identification of the species level was defined as identification of a 16S rDNA sequence that had 99% similarity or greater with that of the GenBank BLAST strain sequence.
Prevention of bacterial contamination
To ensure that no contamination of the PCR preparation occurred, the DNA amplification and the analysis of the amplified products were done in separate laboratories. The preparation was performed on a laminar flow workbench and employed single-use aliquots of reagent and dedicated pipettes. Microfuge tubes and mineral oil aliquots were carefully sterilised prior to use.
RESULTS
Our initial PCR results indicated that bacterial 16S rDNA was positive in 18 ocular fluids of the clinically suspected bacterial endophthalmitis patients (18/19, 95%, table 1). These positive patients had high copy numbers of 16S rDNA ranging from 1.7310 3 to 1.7310 9 copies/ml, which indicated the presence of bacterial infection. In the one PCR-negative case (case 16 in table 1), PCR did not detect any bacterial genome in the vitreous fluid (<100 copies), although Klebsiella pneumoniae was detected in the biopsy sample of the liver abscess.
In the conventional bacterial cultures, 10 (53%) out of the 19 samples were positive (table 1). In addition, positive Gram staining was found in nine (47%) out of these samples. There were only two patients (cases 2 and 4 in table 1) that received intravitreal injections of antibiotics prior to the PCR analysis. As shown in table 1, after examinations that included PCR, all patients received antibiotics (systemic and/or local medications).
With the exception of three out of the 50 uveitis patients, realtime PCR indicated the patients were negative for the bacterial 16S rDNA. Details for the three exceptions are shown in table 1.
The 16S rDNA was detected in two patients with idiopathic uveitis and one with cytomegalovirus (CMV) retinitis. Clinically, all of these patients were diagnosed with unilateral uveitis. Bacterial cultures were negative in all of the tested samples. In addition, bacterial 16S rDNA was not detected in any of the 40 control samples collected from the patients without ocular inflammation.
To identify the specific bacterial species, we used BLAST analysis to examine some of the bacterial infectious endophthalmitis patients. Analysis was only possible when the patient's samples had high amounts of total DNA and there was a detected high copy number of the bacterial 16S rDNA. As summarised in table 1, BLAST analysis identified Staphylococcus epidermidis (case 3), Streptococcus sanguinis (case 6), Bradyrhizobium elkanii (case 7), Enterococcus faecalis (case 11), Pseudomonas sp. PR (case 12), Streptococcus mitis (case 13), Staphylococcus aureus (case 15), Streptococcus pneumoniae (case 17) and Staphylococcus sp. (case 19). The results of the BLAST analysis were identical to the results of the bacterial culture with the exception of case 7, who was found to have a negative culture. However, even though the bacterial examinations such as bacterial cultures and smears were negative in this patient with late postoperative endophthalmitis, broad-range real-time PCR analysis of the vitreous sample yielded positive results (8.1310 7 copies/ml). In the present study, once we were able to determine the bacterial species via the BLAST analysis and conclusively diagnose bacterial endophthalmitis, we were then able to begin treatment with antibiotics.
Case report
As seen in table 1, case 7 was a 75-year-old man who was referred to the uveitis clinic at our hospital during July 2007 due to keratic precipitates, cells and fibrin in the anterior chamber along with hypopyon and anterior vitreous opacity in his right eye (figure 1). The patient had undergone cataract surgery in his right eye 1 year prior to being seen in our clinic. Although visual acuity of his right eye at the time of his initial presentation to our clinic was 0.8, 2 months later, his visual acuity was less than 0.1. A vitreous sample was collected during the pars plana . Broad-range quantitative PCR was also used to measure the bacterial genome in the ocular samples collected from the uveitis patients (n¼50) and from the three patients (6%) that were positive. *Bacterial endophthalmitis after intravitreal injections of bevacizumab. vitrectomy. While bacterial culture and the Gram-staining of the vitreous sample were negative, broad-range and real-time PCR detected 8.1310
7 copies/ml of bacterial 16S rDNA (table 1) . In addition, the BLAST analysis detected Bradyrhizobium elkanii. After the patient was given an intravitreal antibiotic injection (vancomycin and ceftazidime) and systemic antibiotics (levofloxacin), inflammation in his right eye completely disappeared. After receiving treatment, visual acuity in his right eye recovered to 0.9 and there was no severe intraocular tissue damage noted.
DISCUSSION
In the present study, with the exception of one patient, we detected bacterial 16S rDNA in all of the cases that were clinically suspected to have bacterial endophthalmitis. In these patients, high copy numbers of the bacterial DNA were detected, which indicated the presence of a bacterial infection. In the single patient who was suspected of having infectious endophthalmitis but had no bacteria in the ocular sample, K. pneumoniae was detected by biopsy culture for liver infection. Thus, we were ultimately able to diagnose the patient as having endogenous endophthalmitis.
On the other hand, conventional microbiological investigations of the ocular fluid samples, such as bacterial cultures and smears, were negative in about one-half of these patients. Only three of the 50 samples collected from the patients with other clinical entities of uveitis were positive for the broad-range realtime PCR analyses of the bacterial 16S rDNA. In addition, no bacterial 16S rDNA was detected in any of the samples from the control patients without ocular inflammation.
The potential advantage of using PCR is that minute numbers of bacteria can be detected from the very small specimens that are required for the analysis. Chen et al 19 developed this PCR detection method for the eubacterial genome based on the conserved regions of the 16S rRNA sequence (16S rDNA) of Escherichia coli. As the universal primers chosen from 16S rDNA have a large amount of sequence information and highly conserved regions of the gene, primers can be synthesised for a wide variety of bacteria. In addition, the eubacterial primers used had both a high specificity and sensitivity, which was comparable to previous studies.
1 3 Hykin et al 1 examined 29 control vitreous samples and found four that were positive for the eubacterial genome using PCR. In a further study by Therese et al, 3 only a single control sample (5%) was found using the eubacterial-based PCR. In the present study, we did not detect any bacterial 16S rDNA (<100 copies/ml) in any of the samples from the control non-infectious patients when using our broadrange real-time PCR. Thus, another potential advantage of our PCR system is that it provides quantitative information for the bacterial infection. In the present study, we found false positive results (1e100 copies/ml) in only two control samples that we tested, a result that could be due to contamination caused by the conjunctival ocular flora present during the collection of the samples. Other possible causes of the contamination might be related to technical errors that occurred during the PCR preparation or perhaps due to bacterial exposure when collecting the ocular sample.
In cases of bacterial infectious endophthalmitis, it is often difficult to differentiate between inflammation caused by noninfectious and infectious agents. For example, to determine the cause of postoperative inflammation in the eye, we must consider many different possibilities, such as surgical manipulation, toxic lens syndrome, recurrent uveitis (especially if the patient has a previous history) or bacterial endophthalmitis. In the past, microbiological investigations of the ocular fluids have often failed to detect the infectious agent in bacterial endophthalmitis, resulting in a clinical dilemma regarding therapy. Deciding to use antibiotics and steroids necessitates determining whether an inflammation is infectious or sterile. Therefore, an aetiological diagnosis is essential in such cases. The use of PCR with universal eubacterial primers, which possesses broad specificities for all Gram-positive and -negative bacteria, has been recently found to be much more useful for detecting the eubacterial genome in ocular samples of postoperative endophthalmitis cases compared to the routine microbiological investigations. 2 3 5 6 8e10 In the present study, our broad-range real-time PCR for the eubacterial genome showed high correlation with the bacteriologically positive samples. This suggests that bacteriologically negative samples may include the bacterial genome. In a recent report by the French Institutional Endophthalmitis Study Groups, eubacterial PCR was found to be much more effective than bacterial cultures in detecting bacteria in vitreous samples from patients with previous intravitreal administration of antibiotics. 10 Although the previous administration of antibiotics in the PPV vitreous fluids may inhibit bacterial growth, it is assumed that PCR may still be able to detect bacterial DNA of either living or killed bacteria.
As revealed in this study, real-time PCR found only three (6%) of the 50 ocular samples from patients with unilateral uveitis to be positive. However, high copy numbers of bacterial DNA were detected in these uveitis patients, which included idiopathic uveitis (n¼2) and cytomegalovirus retinitis (n¼1). Endophthalmitis and uveitis positive cases with low quantification of DNA (eg, 1310 3 e1310 4 copies/ml) cannot be differentiated according to the number of copies. Although topical or systemic steroids were administered for long periods in the idiopathic uveitis patients, the inflammation remained uncontrolled. It has also been reported that viral PCR has found cytomegalovirus DNA in the eyes of cytomegalovirus retinitis cases. 13 When these patients were given intravitreal administration of an antiviral injection (Ganciclovir), an anterior vitreous opacity was subsequently observed. There were three cases that received antibiotics (intravitreal injection and/or systemic) in our study and the intraocular inflammation, such as vitreous opacity, was well controlled by this antibiotic therapy. Although bacterial DNA amplification in such cases usually suggests contamination, antibiotic administration proved to be effective in our study. Thus, the bacterial PCR-based evidence suggests bacterial involvement in eyes that have a suspected intraocular infection. While PCR for eubacterial detection is necessary for rapid and accurate diagnosis in patients suffering from an unknown intraocular inflammatory disorder, it can also be used to accurately determine samples that are not infected. In our study we found 47 samples (94%) that had negative PCR results. Overall, our results suggest that a sensitive and rapid diagnostic test not only allows for confident verification of the diagnosis (noninfectious inflammation vs infection), but also allows for early commencement of specific and appropriate treatment. In addition, PCR analysis is able to exclude bacterial infections as the potential cause of an ocular disorder.
In conclusion, this new PCR system is an excellent diagnostic system for intraocular specimens and can be used as an alternative to further examine specimens determined to be bacteriologically negative by conventional methods. Our study also clearly demonstrated that a new diagnostic PCR system using eubacterial detection with broad-range PCR along with quantitative evaluation with real-time PCR could be extremely useful for detecting bacterial DNA within ocular samples. Recently, Goldschmidt et al reported that a new diagnostic test for
